**Abbreviations**

**11. The Role of the heart team in the future of multivessel disease**

= two vessel disease.

342 Artery Bypass

The management of CAD with the advances in revascularization techniques and medical therapy, changing patient population and constantly expanding body of knowledge is becoming increasingly more complex. Such complexity would intuitively benefit from a broad spectrum of expertise. There is currently increasing interest in the area of multidisciplinary decision-making and both ACC and ESC have recommended that a Heart Team approach be implemented in the management of UPLM disease or complex CAD *(Class I recommendation, Level C Evidence)* [14, 26]. It is envisioned that with the joint involvement of the interventional cardiologist, the cardiac surgeon and a non-invasive cardiologist, there will be a more balanced, consistent management of these complex cases. From the patient's perspective, this approach would conceivably allow them to be more informed and involved in the ultimate

**Figure 10.** Suggested approach for decision making in multivessel coronary artery disease. CAD= coronary artery dis‐ ease; CABG= coronary artery bypass grafting; LAD= left anterior descending artery; LM = left main disease; LV= Left Ventricular; OMT= optimal medical therapy; PCI= percutaneous coronary intervention; SCD= sudden cardiac death; SYNTAX = The Synergy between PCI with Taxus and Cardiac Surgery; T2DM= Type 2 Diabetes Mellitis; UA/NSTEMi = unstable angina/Non ST elevation myocardial infarction; VT= ventricular tachycardia; 3VD = Three vessel disease; 2VD


**References**

2010(114): p. 1-4.

1962. 31: p. 735.

p. 1421-2.

N Engl J Med, 2012. 366(1): p. 54-63.

culation, 2011. 124(22): p. 2458-73.

Interv, 2012. 5(6): p. 618-25.

1011-4.

[1] Macklem, P.T., *Stephen Hales, an unrecognized giant of medicine.* Osler Libr Newsl,

Multivessel Disease in the Modern Era of Percutaneous Coronary Intervention

http://dx.doi.org/10.5772/55103

345

[2] Bourassa, M.G., *The history of cardiac catheterization.* Can J Cardiol, 2005. 21(12): p.

[3] Proudfit, W.L., E.K. Shirey, and F.M. Sones, Jr., *Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients.* Circulation, 1966. 33(6): p. 901-10. [4] Sones, F.M.J. and E.K. Shirey, *Cine coronary arteriography.* Mod Con Cardiov Dis,

[5] Mueller, R.L. and T.A. Sanborn, *The history of interventional cardiology: cardiac catheteri‐ zation, angioplasty, and related interventions.* Am Heart J, 1995. 129(1): p. 146-72.

[6] Berry, D., *The unlocking of the coronary arteries: origins of angioplasty. A short historical review of arterial dilatation from Dotter to the creative Gruentzig.* Eur Heart J, 2009. 30(12):

[7] Nabel, E.G. and E. Braunwald, *A tale of coronary artery disease and myocardial infarction.*

[8] Smith, S.C., Jr., et al., *AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.* Cir‐

[9] Head, S.J., et al., *Risk profile and 3-year outcomes from the SYNTAX percutaneous coro‐ nary intervention and coronary artery bypass grafting nested registries.* JACC Cardiovasc

[10] Fuster, R.G., et al., *Prognostic value of chronic obstructive pulmonary disease in coronary*

[11] Ried, M., et al., *Mild-to-moderate COPD as a risk factor for increased 30-day mortality in*

[12] Hirshfeld, J.W., Jr., et al., *American College of Cardiology training statement on recommen‐ dations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology task force on clinical expert consensus docu‐*

[13] Ryan, T.J., K. F.J., and R. W.A., *Clinical competence in percutaneous transluminal coro‐ nary angioplasty. A statement for physicians from the ACP/ACC/AHA Task Force on Clini‐*

[14] Levine, G.N., et al., *2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Inter‐ vention: a report of the American College of Cardiology Foundation/American Heart Associa‐*

*artery bypass grafting.* Eur J Cardiothorac Surg, 2006. 29(2): p. 202-9.

*cardiac surgery.* Thorac Cardiovasc Surg, 2010. 58(7): p. 387-91.

*cal Privileges in Cardiology.* Circulation, 1990. 81(6): p. 2041-6.

*ments.* J Am Coll Cardiol, 1999. 34(7): p. 2141-7.
